Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
1,212
Showing 50 of 1,212
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 51 | ARQT | Arcutis Biotherapeutics, Inc. | 19/21 | 8 | 100% | +116.7% | +61.2% | +249.4% | +15.3% |
| 52 | INBX | Inhibrx Biosciences, Inc. | 29 | 5 | 76% | +115.0% | +87.7% | +474.8% | -24.9% |
| 53 | AEYE | Audioeye Inc | 13/26 | 6 | 77% | +113.9% | +60.1% | +345.2% | -51.6% |
| 54 | AISP | Airship Ai Holdings, Inc. | 22/32 | 7 | 64% | +112.7% | +189.2% | +305.3% | -76.9% |
| 55 | UTI | Universal Technical Institute Inc | 35/67 | 6 | 100% | +112.2% | +113.2% | +132.0% | +86.2% |
| 56 | FTEK | Fuel Tech, Inc. | 14/15 | 3 | 93% | +112.2% | +79.6% | +259.4% | -16.7% |
| 57 | PLSE | Pulse Biosciences, Inc. | 36/41 | 5 | 81% | +111.5% | +132.3% | +169.3% | -23.2% |
| 58 | MPLN | Multiplan Corp | 17/33 | 8 | 59% | +111.1% | +30.8% | +517.0% | -49.3% |
| 59 | PYXS | Pyxis Oncology, Inc. | 13 | 4 | 100% | +111.0% | +102.2% | +198.3% | +77.5% |
| 60 | AEVA | Aeva Technologies, Inc. | 21 | 4 | 100% | +110.1% | +88.0% | +226.2% | +45.7% |
| 61 | AMPG | Amplitech Group, Inc. | 20/22 | 4 | 90% | +109.4% | +18.2% | +481.1% | -25.6% |
| 62 | BTSG | Brightspring Health Services, Inc. | 21 | 17 | 100% | +108.9% | +107.0% | +111.8% | +107.0% |
| 63 | ACIC | American Coastal Insurance Corp | 25/36 | 8 | 84% | +107.5% | +57.0% | +241.1% | -8.4% |
| 64 | XERS | Xeris Biopharma Holdings, Inc. | 12/13 | 8 | 92% | +106.9% | +88.4% | +224.4% | -5.1% |
| 65 | APEI | American Public Education Inc | 206 | 14 | 100% | +106.5% | +105.3% | +245.9% | +73.7% |
| 66 | CDE | Coeur Mining, Inc. | 17/18 | 8 | 71% | +105.8% | +82.6% | +404.9% | -31.0% |
| 67 | FLME | Flame Acquisition Corp. | 16/20 | 6 | 81% | +105.1% | +140.7% | +153.1% | -24.8% |
| 68 | FLNC | Fluence Energy, Inc. | 24 | 9 | 88% | +103.8% | +72.6% | +274.0% | -65.5% |
| 69 | EWTX | Edgewise Therapeutics, Inc. | 17/18 | 5 | 100% | +103.6% | +141.8% | +211.6% | +28.2% |
| 70 | FSTR | Foster L B Co | 20 | 10 | 100% | +102.9% | +135.1% | +169.7% | +22.6% |
| 71 | QNST | Quinstreet, Inc | 10 | 6 | 90% | +101.3% | +112.9% | +137.4% | -27.5% |
| 72 | GDNSF | Goodness Growth Holdings, Inc. | 197/245 | 8 | 49% | +100.7% | -0.8% | +3308.1% | -38.5% |
| 73 | PI | Impinj Inc | 50/54 | 4 | 86% | +99.9% | +122.2% | +176.6% | -18.0% |
| 74 | BUKS | Butler National Corp | 161/187 | 5 | 99% | +97.9% | +98.6% | +170.6% | -17.5% |
| 75 | OUST | Ouster, Inc. | 23/26 | 4 | 87% | +96.5% | +78.8% | +295.0% | -7.1% |
| 76 | TRDA | Entrada Therapeutics, Inc. | 110/175 | 7 | 88% | +96.3% | +112.5% | +125.1% | -43.9% |
| 77 | NGL | Ngl Energy Partners LP | 10/11 | 3 | 80% | +96.2% | +118.5% | +166.1% | -27.4% |
| 78 | APLD | Applied Digital Corp. | 34 | 4 | 88% | +94.8% | +100.7% | +240.5% | -48.1% |
| 79 | RAVE | Rave Restaurant Group, Inc. | 96 | 9 | 100% | +92.0% | +93.2% | +104.7% | +29.9% |
| 80 | PCT | Purecycle Technologies, Inc. | 16/17 | 12 | 81% | +91.3% | +54.5% | +282.9% | -37.9% |
| 81 | DK | Delek US Holdings, Inc. | 18 | 6 | 83% | +90.7% | +92.7% | +203.9% | -59.9% |
| 82 | CORZ | Core Scientific, Inc./Tx | 17/19 | 6 | 100% | +89.6% | +59.7% | +157.5% | +35.7% |
| 83 | PACK | Ranpak Holdings Corp. | 33 | 7 | 91% | +89.2% | +120.7% | +138.3% | -71.3% |
| 84 | BVS | Bioventus Inc. | 25 | 5 | 92% | +88.5% | +67.3% | +219.5% | -17.3% |
| 85 | JANX | Janux Therapeutics, Inc. | 35 | 10 | 29% | +88.2% | -54.4% | +645.3% | -55.7% |
| 86 | ASMB | Assembly Biosciences, Inc. | 13/14 | 3 | 100% | +87.8% | +90.8% | +152.7% | +12.7% |
| 87 | TCRX | Tscan Therapeutics, Inc. | 68/74 | 12 | 72% | +87.3% | +143.7% | +201.8% | -78.0% |
| 88 | DRUG | Bright Minds Biosciences Inc. | 35 | 3 | 100% | +86.3% | +76.8% | +130.6% | +1.4% |
| 89 | FEIM | Frequency Electronics Inc | 17 | 4 | 100% | +86.1% | +68.5% | +175.7% | +51.1% |
| 90 | LQDA | Liquidia Corp | 24/26 | 8 | 100% | +85.4% | +49.8% | +200.5% | +30.0% |
| 91 | ACLX | Arcellx, Inc. | 31 | 16 | 100% | +83.7% | +75.2% | +108.1% | +75.2% |
| 92 | SNWV | Sanuwave Health, Inc. | 12/13 | 6 | 83% | +83.6% | +83.2% | +140.3% | -35.5% |
| 93 | KYMR | Kymera Therapeutics, Inc. | 316/370 | 16 | 66% | +83.2% | +45.7% | +284.7% | -16.3% |
| 94 | MBX | Mbx Biosciences, Inc. | 44/52 | 25 | 41% | +83.0% | -55.0% | +446.8% | -55.0% |
| 95 | CPS | Cooper-Standard Holdings Inc. | 12/18 | 7 | 100% | +82.9% | +72.9% | +165.4% | +20.9% |
| 96 | NN | Nextnav Inc. | 36/37 | 4 | 94% | +82.5% | +85.2% | +259.0% | -0.7% |
| 97 | LGCY | Legacy Education Inc. | 40/41 | 5 | 100% | +82.3% | +95.0% | +148.5% | +8.8% |
| 98 | VST | Vistra Corp. | 22 | 6 | 95% | +82.0% | +58.8% | +250.7% | -5.7% |
| 99 | ESOA | Energy Services of America Corp | 26/31 | 5 | 85% | +81.5% | +33.8% | +246.8% | -30.2% |
| 100 | IMNM | Immunome Inc. | 16/24 | 5 | 75% | +80.7% | +96.7% | +192.1% | -42.0% |